Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2022
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Direct |
24,115
+17.52%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
12,231
+9.25%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
36,346
-100.0%
|
-
|
|
Nov 18
2022
|
Philip Ebeling Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
167
-40.73%
|
-
|
|
Nov 11
2022
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
9,217
-57.05%
|
$2,036,957
$221.58 P/Share
|
|
Nov 11
2022
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,277
+37.5%
|
$0
$0.94 P/Share
|
|
Nov 08
2022
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
2,000
-8.83%
|
-
|
|
Oct 17
2022
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+14.99%
|
$0
$0.94 P/Share
|
|
Oct 11
2022
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
35,117
+49.14%
|
-
|
|
Oct 11
2022
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Direct |
35,117
-28.19%
|
-
|
|
Oct 11
2022
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
129
+3.09%
|
$21,672
$168.98 P/Share
|
|
Oct 11
2022
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+20.0%
|
$13,608
$168.98 P/Share
|
|
Oct 11
2022
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51
+50.0%
|
$8,568
$168.98 P/Share
|
|
Oct 11
2022
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.41%
|
$13,608
$168.98 P/Share
|
|
Oct 11
2022
|
Timothy P. Herbert CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
68,787
+13.12%
|
$1,169,379
$17.82 P/Share
|
|
Oct 11
2022
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
88
+3.85%
|
$14,784
$168.98 P/Share
|
|
Oct 11
2022
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+14.91%
|
$14,280
$168.98 P/Share
|
|
Sep 23
2022
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,218
+26.98%
|
$0
$0.94 P/Share
|
|
Jul 11
2022
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+22.36%
|
$13,510
$193.86 P/Share
|
|
Jul 11
2022
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
119
+2.95%
|
$22,967
$193.86 P/Share
|
|
Jul 11
2022
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.4%
|
$14,861
$193.86 P/Share
|
|
Jul 11
2022
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
67
+14.35%
|
$12,931
$193.86 P/Share
|
|
Jul 11
2022
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+3.52%
|
$14,861
$193.86 P/Share
|
|
Apr 18
2022
|
Timothy P. Herbert CEO and President |
BUY
Exercise of conversion of derivative security
|
Indirect |
17,417
+32.77%
|
$17,417
$1.31 P/Share
|
|
Apr 08
2022
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+2.34%
|
$23,114
$254.08 P/Share
|
|
Apr 08
2022
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+2.82%
|
$14,986
$254.08 P/Share
|
|
Apr 08
2022
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
51
+13.28%
|
$12,954
$254.08 P/Share
|
|
Apr 08
2022
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.3%
|
$14,986
$254.08 P/Share
|
|
Apr 08
2022
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
54
+23.79%
|
$13,716
$254.08 P/Share
|
|
Apr 01
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
10,000
-5.98%
|
$2,670,000
$267.5 P/Share
|
|
Apr 01
2022
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-6.6%
|
$3,855,000
$257.96 P/Share
|
|
Mar 29
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
10,098
-3.6%
|
$2,574,990
$255.0 P/Share
|
|
Mar 29
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Indirect |
97,416
-37.46%
|
$24,451,416
$251.35 P/Share
|
|
Mar 29
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Direct |
27,759
-8.13%
|
$6,967,509
$251.34 P/Share
|
|
Mar 28
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
2,323
-2.36%
|
$580,750
$250.0 P/Share
|
|
Mar 28
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Indirect |
2,542
-2.07%
|
$635,500
$250.0 P/Share
|
|
Mar 28
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Direct |
1,546
-1.28%
|
$386,500
$250.0 P/Share
|
|
Mar 25
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
2,579
-2.55%
|
$644,750
$250.01 P/Share
|
|
Mar 25
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Indirect |
42
-0.03%
|
$10,500
$250.0 P/Share
|
|
Mar 25
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Direct |
695
-0.57%
|
$173,750
$250.0 P/Share
|
|
Mar 17
2022
|
Timothy P. Herbert CEO and President |
SELL
Open market or private sale
|
Direct |
20,000
-4.77%
|
$4,520,000
$226.34 P/Share
|
|
Feb 18
2022
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
250
+10.0%
|
-
|
|
Feb 18
2022
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
250
-0.4%
|
-
|
|
Feb 17
2022
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
250
+10.0%
|
-
|
|
Feb 17
2022
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
250
-0.4%
|
-
|
|
Jan 29
2022
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-9.01%
|
$42,640
$208.0 P/Share
|
|
Jan 27
2022
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
29,976
+17.66%
|
-
|
|
Jan 27
2022
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Direct |
29,976
-19.4%
|
-
|
|
Jan 27
2022
|
Timothy P. Herbert CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
37,993
+21.24%
|
$75,986
$2.07 P/Share
|
|
Jan 24
2022
|
Timothy P. Herbert CEO and President |
BUY
Bona fide gift
|
Indirect |
25,000
+41.77%
|
-
|